The Limited Times

Now you can see non-English news...

CVS withdraws Zantac and similar medications for heartburn due to cancer concerns

2019-10-01T08:08:15.586Z


CVS Pharmacy has stopped selling Zantac, as well as its generic version of the heartburn medication, for the concern that they may contain a substance that can cause cancer.…


  • Click to share on Facebook (Opens in a new window)
  • Click to share on Twitter (Opens in a new window)
  • Click here to share on LinkedIn (Opens in a new window)
  • Click to email a friend (Opens in a new window)

(CNN) - CVS Pharmacy has stopped selling Zantac, as well as its generic version of the heartburn medication, for the concern that they may contain a substance that can cause cancer.

MIRA: Stop distribution of ranitidine medications for heartburn (found contaminants)

CVS, the largest pharmacy chain in the United States, said over the weekend that it would suspend the sale of Zantac and other products containing ranitidine until further notice. The US Food and Drug Administration. UU. (FDA) said earlier this month that it learned that some ranitidines, medications to reduce stomach acid and heartburn, including those known under the brand name Zantac, contain low levels of impurity that could cause cancer

Zantac and its generic counterpart have not been recalled, a CVS statement said, and the FDA has not recommended that patients stop taking ranitidine products.

Customers can return the products

The nitrosamine impurity known as N-nitrosodimethylamine, or NDMA, has been classified as a probable human carcinogen, according to laboratory tests, and this is not the first time it has been detected in a common medicine.

Since last year, the FDA has been investigating NDMA and other impurities in medications for blood pressure and heart failure known as angiotensin receptor blockers or BRA. Numerous recalls have been launched as the FDA found "unacceptable levels" of nitrosamines in several of those common medications that contain valsartan.

READ: Heartburn medications can cause allergies, says study

A study published last year in the medical journal BMJ did not find a "noticeably increased overall risk of short-term cancer" among users of valsartan drugs contaminated with NDMA. However, that study also noted that research is needed on long-term cancer risk.

Customers who have already purchased the products can return them for a refund, CVS said.

Jacqueline Howard and Jamie Gumbrecht of CNN contributed to this report.

Heartburn

Source: cnnespanol

All news articles on 2019-10-01

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.